Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Second phase I study of OGX-011 begins

April 9, 2003

Merck presents new tyrosine kinase inhibitors for cancer and other angiogenesis-related disorders

April 9, 2003

Thienopyridines targeting VEGFR tyrosine kinase presented by Pfizer

April 8, 2003

Histone deacetylase inhibitors derived from SAHA presented at ACS meeting

April 8, 2003

Water-soluble taxoids for use in tumor-activated prodrugs

April 7, 2003

Brand name announced for decitabine

April 7, 2003

AP-5346 enters phase I trials in Europe

April 7, 2003

New antitumor duocarmycin analogues covered by Medarex patent

April 7, 2003

Novel PARP inhibitors in early development at Icos

April 7, 2003

Food intake does not alter the pharmacokinetics of multiple-dose lonafarnib

April 7, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 18, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...